NASOPHARYNGEAL CANCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CANCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for advanced throat cancer
Disease control OngoingThis study tests a treatment for people with nasopharyngeal cancer that has spread to other parts of the body. The treatment combines an immunotherapy drug (tislelizumab) with chemotherapy and radiation therapy that is adjusted based on how well the tumor responds. The goal is to…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: NA • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Extra pill after treatment could stop deadly head & neck Cancer's return
Disease control OngoingThis study is for people with a specific, high-risk type of nasopharyngeal cancer (a cancer in the upper throat). All participants get the standard treatment of chemotherapy and radiation together. For those whose blood tests still show signs of the cancer virus during treatment,…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE3 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC